Oculis Holding AG

NASDAQ (USD): Oculis Holding AG (OCS)

Last Price

16.99

Today's Change

0.00 (0.00%)

Day's Change

0.00 - 0.00

Trading Volume

0

Overview

Market Cap

692 Million

Shares Outstanding

40 Million

Avg Volume

51,896

Avg Price (50 Days)

15.96

Avg Price (200 Days)

12.95

PE Ratio

-9.18

EPS

-1.85

Earnings Announcement

17-Mar-2025

Previous Close

16.89

Open

17.10

Day's Range

16.905 - 17.0988

Year Range

10.105 - 18.0

Trading Volume

3,172

Price Change Highlight

1 Day Change

0.59%

5 Day Change

-0.12%

1 Month Change

10.54%

3 Month Change

40.18%

6 Month Change

43.38%

Ytd Change

53.76%

1 Year Change

54.45%

3 Year Change

75.15%

5 Year Change

75.15%

10 Year Change

75.15%

Max Change

75.15%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Oculis Holding AG, a clinical-stage biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. The company's lead candidate is OCS-01, a topical dexamethasone formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for keratoconjunctivitis sicca, or dry eye disease; and OCS-05, a novel neuroprotective agent for acute optic neuritis and other neuro-ophtha disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company is based in Zug, Switzerland.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment